Clinical trial
Analgesic Efficacy of Posterior Versus Transmuscular Quadratus Lumborum Block in Children Undergoing Unilateral Lower Abdominal Surgery: A Randomized Controlled Trial
NCT07926269 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analgesic Efficacy of Posterior Versus Transmuscular Quadratus Lumborum Block in Children Undergoing Unilateral Lower Abdominal Surgery: A Randomized Controlled Trial
- Lead sponsor
- Beni-Suef University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- May 31, 2027
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hydrocele, inguinal hernias, postoperative pain, undescended testis
Arms
As registered; 2 arms.
-
Posterior QLB (QL2)
Children assigned to this arm receive a single-dose, ultrasound-guided posterior quadratus lumborum block (QL2) performed after induction of general anesthesia and prior to surgical incision. Under ultrasound guidance, a short-bevel echogenic needle is advanced to the posterior surface of the quadratus lumborum muscle within the lumbar interfascial triangle (LIFT). Local anesthetic is deposited following hydrodissection confirmation and negative aspiration.
-
Transmuscular QLB (QL3)
Children assigned to this arm receive a single-dose, ultrasound-guided transmuscular quadratus lumborum block (QL3) performed after induction of general anesthesia and prior to surgical incision. Under ultrasound guidance using the "Shamrock" view, a short-bevel needle is advanced transmuscularly through the quadratus lumborum muscle to deposit local anesthetic in the fascial plane between its anterior surface and the psoas major muscle following hydrodissection confirmation and negative aspiration.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Total Cumulative Opioid Consumption in the First 24 Hours
Total cumulative dose of intraoperative and postoperative rescue opioids administered during the first 24 hours postoperatively, converted to intravenous morphine-equivalent doses (mg/kg) using standard conversion ratios and normalized to body weight. A lower numerical value indicates a superior clinical outcome (greater opioid-sparing effect and reduced opioid requirement).
Lead sponsor's other trials
Beni-Suef University, most recent start first.
+343 more trials See the organization page
Similar trials
Same condition (Testicular Hydrocele) and phase, most recent start first.
+6 more trials See the condition page